ELVN Competitors & Alternatives
Compare Enliven Therapeutics Inc. with similar stocks in the same industry
Biotechnology
ELVN
Main Stock$46.21
Tradestie Score
63
Market Cap
$1.17B
Analyst Upside
+59.9%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ADMA
ADMA Biologics, Inc.
|
$9.93
|
$3.59B | 14.3 | 29 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$19.89
|
$3.58B | 9.0 | 58 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$302.74
|
$3.49B | 32.1 | 44 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.72
|
$3.40B | 109.7 | 36 | Compare |
|
QURE
uniQure N.V.
|
$23.37
|
$3.39B | - | 46 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$46.16
|
$3.33B | - | 70 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$24.16
|
$3.31B | - | 52 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$23.72
|
$3.09B | - | 50 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$30.51
|
$3.08B | - | 48 | Compare |
More ELVN Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry